Related Experiment Video

Updated: Dec 9, 2025

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
10:26

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes

Published on: January 16, 2015

8.7K

Mass administration of azithromycin reduces childhood mortality in Niger

Sarah Murphy1, Mehreen S Datoo2

  • 1Department of Paediatrics, Mercy University Hospital, Cork, Ireland sarah.murphy11@nhs.net.

Archives of Disease in Childhood. Education and Practice Edition
|September 9, 2020
PubMed
Abstract

No abstract available in PubMed .

Keywords:
epidemiologymortality

More Related Videos

Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections
06:19

Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections

Published on: October 11, 2024

3.1K
Using Mycobacterium smegmatis as a Bioindicator for Zinc-Limited Growth Conditions in Mycobacteria
08:24

Using Mycobacterium smegmatis as a Bioindicator for Zinc-Limited Growth Conditions in Mycobacteria

Published on: September 20, 2024

809

Related Experiment Videos

Last Updated: Dec 9, 2025

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes
10:26

Toxicological Assays for Testing Effects of an Epigenetic Drug on Development, Fecundity and Survivorship of Malaria Mosquitoes

Published on: January 16, 2015

8.7K
Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections
06:19

Author Spotlight: Characterizing Airway Environments to Advance Model Systems and Antimicrobial Discovery in Cystic Fibrosis and Chronic Respiratory Infections

Published on: October 11, 2024

3.1K
Using Mycobacterium smegmatis as a Bioindicator for Zinc-Limited Growth Conditions in Mycobacteria
08:24

Using Mycobacterium smegmatis as a Bioindicator for Zinc-Limited Growth Conditions in Mycobacteria

Published on: September 20, 2024

809

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

131
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
131

Articles linked to this work by shared authors, journal, and citation graph.

Malaria vaccine protection against intradermal or venous parasites: a randomized phase 2b human challenge trial.

Nature medicine·2026

R21/Matrix-M malaria vaccine drives diverse immune responses in pre-exposed adults: insights from a phase IIb controlled human malaria infection trial.

Frontiers in immunology·2025

R21 in Matrix-M adjuvant in UK malaria-naive adult men and non-pregnant women aged 18-45 years: an open-label, partially blinded, phase 1-2a controlled human malaria infection study.

The Lancet. Microbe·2025

Evaluation of a novel malaria anti-sporozoite vaccine candidate, R21 in Matrix-M adjuvant, in the UK and Burkina Faso: two phase 1, first-in-human trials.

The Lancet. Microbe·2025

Safety and immunogenicity of varied doses of R21/Matrix-M™ vaccine at three years follow-up: A phase 1b age de-escalation, dose-escalation trial in adults, children, and infants in Kilifi-Kenya.

Wellcome open research·2024

The public health impact and cost-effectiveness of the R21/Matrix-M malaria vaccine: a mathematical modelling study.

The Lancet. Infectious diseases·2024

Fifteen minute consultation: managing children with HNF1B pathogenic variants.

Archives of disease in childhood. Education and practice edition·2026

Fifteen-minute consultation:The mimics of cerebral palsy-looks like CP but isn't.

Archives of disease in childhood. Education and practice edition·2026

How to give and receive feedback: closing the feedback gap.

Archives of disease in childhood. Education and practice edition·2026

Squint, stomach and sick kidneys: a teen's troubling trio.

Archives of disease in childhood. Education and practice edition·2026

Fifteen-minute consultation: Delayed puberty in girls.

Archives of disease in childhood. Education and practice edition·2026

UndeFEETed: quality improvement to increase rates of documented diabetic foot exams for outpatient type 2 diabetes paediatric patients.

Archives of disease in childhood. Education and practice edition·2026

Targeting glutathione peroxidase 4 in ferroptosis: from immune regulation to pharmacological development and translational applications.

Frontiers in pharmacology·2026

Medical AI across Data Regimes to Promote Proactive Health.

Health data science·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us